The Drug Resistance Workshop 2010 will be held on Wed 12 May 2010 at the Hammersmith Conference Centre, Hammersmith Hospital, London. For more information about the meeting and a registration package please contact ernesto.yague@imperial.ac.uk Chemotherapy is still one of the major therapies used to treat cancer. Unfortunately, resistance to chemotherapeutic treatment remains the main cause of cancer mortality. Notable advances have been done in the last years to understand the basic mechanisms underlying drug resistance and its implications in the clinical practice.

The mechanisms needed to ensure clinical proteomic discoveries are translated to the clinic are a major challenge, both in defining them and establishing them. The goal of this conference is to discuss the most effective ways in which discoveries such as novel biomarkers can be integrated with current clinical laboratory medicine for the benefit of the patient. Further information can be found at: https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=123

In this scientific meeting, we will focus on personalised medicine and its impact on the use of novel therapeutics. We will discuss the clinical impact of these developments and the importance of the laboratory and regulatory changes on this aim.

Aim: This year’s meeting will particularly concentrate on the patterns of spread of common cancers and recent changes. It will also provide an overview of current and emerging applications of PET/CT in oncology. Objectives: The two day conference on PET/CT will bring together leading European experts in the field of PET/CT.

The European Workshop on Cytogenetics and Molecular Genetics of Solid Tumors is one of the most relevant cancer research meetings in Europe. The workshop will take place at the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. During previous workshops we have witnessed the emergence of novel insights into the role of chromosomal abnormalities and gene mutations in the development of both hereditary and non-hereditary human solid tumors. Now we are moving into a new era in which comprehensive sequence-based information on vast numbers of tumors can be obtained.

The next international symposium of the Cambridge Research Institute will take place on 19-20 March 2010.
The topic is “Unanswered Questions in Tumour Monitoring” with sessions in:

• The translation barrier: problems and solutions in moving from animal models to clinical trials
• The potential clinical use of MRS in oncology
• Detecting genomic biomarkers from high-dimensional clinical data
• Opportunities of preneoplasia for a pre-emptive strike

Each session consists of invited talks and one selected talk, and a 45 min panel discussion.  As in previous years, we have a great list of speakers,  further details can be found at the website: http://www.cambridgecancer.org.uk/seminars/symposium/programme?version=6
 Registration fees are: £375 for full registration or £150 for non-residential registration. 
We hope you may be able to join us and make this a successful meeting.  To register: http://science.cancerresearchuk.org/groups/cri_symposium/registration/
 

• Organised by the SCI Fine Chemicals Group and the Biological and Medicinal Chemistry Sector of the RSC
• Full details at SCI meeting website

Synopsis This symposium will showcase exciting developments in cancer drug discovery, from both an academic and industrial perspective. Topics will range from the characterisation of potential new drug targets through to medicinal chemistry case studies and the identification of clinical drug candidates. A key feature of this event is to create an opportunity for interaction and discussion between scientists from academia and industry.

Website: www.aicrconference2010.co.uk AICR, the Association for International Cancer Research would be delighted if you could join us in celebrating our 30th anniversary in 2010. We have arranged an international scientific conference entitled “Today’s Research – Tomorrow’s Therapies” to be held in the historic city of St Andrews, Fife, Scotland from 7 to 9 April 2010.

Breast Cancer Research 2010 Conference

Achievements in breast cancer research is the theme of the Breast Cancer Research 2010 which takes place at the Royal Society in the heart of London on 18 May 2010. It is open to all researchers with an interest in breast cancer.

Breast Cancer Campaign’s key objectives are to build the talent pool in breast cancer research, encourage scientific innovation, engage in scientific and public dialogue and ensure research that translates into patient benefit continues.